BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25476872)

  • 1. Delayed-Phase Cone-Beam CT Improves Detectability of Intrahepatic Cholangiocarcinoma During Conventional Transarterial Chemoembolization.
    Schernthaner RE; Lin M; Duran R; Chapiro J; Wang Z; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Aug; 38(4):929-36. PubMed ID: 25476872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.
    Schernthaner RE; Haroun RR; Duran R; Lee H; Sahu S; Sohn JH; Chapiro J; Zhao Y; Gorodetski B; Fleckenstein F; Smolka S; Radaelli A; van der Bom IM; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1429-37. PubMed ID: 27380872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visibility of Hypovascularized Liver Tumors during Intra-Arterial Therapy Using Split-Bolus Single-Phase Cone Beam CT.
    Jonczyk M; Collettini F; Schnapauff D; Geisel D; Böning G; Lüdemann WM; Wieners G; Hamm B; Gebauer B
    Cardiovasc Intervent Radiol; 2019 Feb; 42(2):260-267. PubMed ID: 30374613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation exposure during TACE procedures using additional cone-beam CT (CBCT) for guidance: safety and precautions.
    Jonczyk M; Collettini F; Geisel D; Schnapauff D; Böning G; Wieners G; Gebauer G
    Acta Radiol; 2018 Nov; 59(11):1277-1284. PubMed ID: 29490465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
    Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
    Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic 4D-CT Angiography for Guiding Transarterial Chemoembolization: Impact on the Reduction of Contrast Material, Operator Radiation Exposure, Catheter Consumption, and Diagnostic Confidence.
    Albrecht MH; Vogl TJ; Wichmann JL; Martin SS; Scholtz JE; Fischer S; Hammerstingl RM; Harth M; Nour-Eldin NA; Thalhammer A; Zangos S; Bauer RW
    Rofo; 2018 Jun; 190(6):513-520. PubMed ID: 29763951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization.
    Bannangkoon K; Hongsakul K; Tubtawee T
    BMC Gastroenterol; 2021 Nov; 21(1):419. PubMed ID: 34749658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
    Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M
    Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    Cho Y; Lee S; Park SJ
    PLoS One; 2021; 16(1):e0245911. PubMed ID: 33513172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraprocedural cone-beam CT with parenchymal blood volume assessment for transarterial chemoembolization guidance: Impact on the effectiveness of the individual TACE sessions compared to DSA guidance alone.
    Peisen F; Maurer M; Grosse U; Nikolaou K; Syha R; Artzner C; Bitzer M; Horger M; Grözinger G
    Eur J Radiol; 2021 Jul; 140():109768. PubMed ID: 33991970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    J Vasc Interv Radiol; 2013 Apr; 24(4):501-8. PubMed ID: 23452552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
    Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
    Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
    Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):388-95. PubMed ID: 23775550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new angiographic imaging platform reduces radiation exposure for patients with liver cancer treated with transarterial chemoembolization.
    Schernthaner RE; Duran R; Chapiro J; Wang Z; Geschwind JF; Lin M
    Eur Radiol; 2015 Nov; 25(11):3255-62. PubMed ID: 25956933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?
    Pellerin O; Pereira H; Van Ngoc Ty C; Moussa N; Del Giudice C; Pernot S; Déan C; Chatellier G; Sapoval M
    Eur Radiol; 2019 Oct; 29(10):5253-5263. PubMed ID: 30937583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-automatic prostatic artery detection using cone-beam CT during prostatic arterial embolization.
    Schnapauff D; Maxeiner A; Wieners G; Denecke T; Hamm B; Gebauer B; Jonczyk M
    Acta Radiol; 2020 Aug; 61(8):1116-1124. PubMed ID: 31830430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
    Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of automated cone-beam CT vessel identification software during transarterial hepatic embolisation: radiation dose, contrast medium volume, processing time, and operator perspectives compared to digital subtraction angiography.
    Durack JC; Brown KT; Avignon G; Brody LA; Sofocleous CT; Erinjeri JP; Solomon SB
    Clin Radiol; 2018 Dec; 73(12):1057.e1-1057.e6. PubMed ID: 30220595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging guidance with C-arm CT: prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization.
    Kothary N; Abdelmaksoud MH; Tognolini A; Fahrig R; Rosenberg J; Hovsepian DM; Ganguly A; Louie JD; Kuo WT; Hwang GL; Holzer A; Sze DY; Hofmann LV
    J Vasc Interv Radiol; 2011 Nov; 22(11):1535-43. PubMed ID: 21875814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.